These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
880 related items for PubMed ID: 17457386
21. Prescription of psychotropic drugs in adolescent psychiatry wards in Finland. Haapasalo-Pesu KM, Erkolahti R, Saarijärvi S, Aalberg V. Nord J Psychiatry; 2004; 58(3):213-8. PubMed ID: 15204208 [Abstract] [Full Text] [Related]
22. Ocular anomalies of individuals with mental illness and dual diagnosis. Maino DM, Rado ME, Pizzi WJ. J Am Optom Assoc; 1996 Dec; 67(12):740-8. PubMed ID: 9286315 [Abstract] [Full Text] [Related]
23. Rational use and rationale for use: psychiatric medication at an Argentine institution for intellectual disability. de Menil V, Cohen A. Transcult Psychiatry; 2009 Dec; 46(4):651-71. PubMed ID: 20028682 [Abstract] [Full Text] [Related]
24. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness. Haw C, Stubbs J. J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284 [Abstract] [Full Text] [Related]
25. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada. Sarma S, Basu K, Gupta A. Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377 [Abstract] [Full Text] [Related]
26. [Polypharmacy in psychiatric patients as an alternative to limited mental health resources]. de las Cuevas C, Sanz EJ, de la Fuente JA, Cueto M. Actas Esp Psiquiatr; 2005 Dec; 33(2):81-6. PubMed ID: 15768314 [Abstract] [Full Text] [Related]
27. [Off-label use of psychotropic medications in pediatric wards: a prospective study]. Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O. Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689 [Abstract] [Full Text] [Related]
28. Psychotropic medication of mentally retarded residents in community long-term care facilities. Buck JA, Sprague RL. Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316 [Abstract] [Full Text] [Related]
29. Psychiatric illness in mental retardation: an update on pharmacotherapy. Masi G, Luccherino L. Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071 [Abstract] [Full Text] [Related]
34. [Psychotropic medications use in Spain. Results of the ESEMeD-Spain study]. Codony M, Alonso J, Almansa J, Vilagut G, Domingo A, Pinto-Meza A, Fernández A, Serrano-Blanco A, Márquez M, Haro JM. Actas Esp Psiquiatr; 2007 Sep; 35 Suppl 2():29-36. PubMed ID: 18264867 [Abstract] [Full Text] [Related]
35. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation. de Bildt A, Mulder EJ, Scheers T, Minderaa RB, Tobi H. Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506 [Abstract] [Full Text] [Related]
36. Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study. Orringer JS, Helfrich YR, Hamilton T, Friedman C, Johnson TM, Sachs DL. J Am Acad Dermatol; 2006 Mar; 54(3):416-9. PubMed ID: 16488291 [Abstract] [Full Text] [Related]
38. Comparative survey of drug use in a community service system. Zaharia ES, Struxness L. Ment Retard; 1991 Aug; 29(4):191-4. PubMed ID: 1921727 [Abstract] [Full Text] [Related]
40. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study. Baker JA, Lovell K, Harris N. Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]